Pharmaceutical compositions comprising GLP-1 peptides or exendin-4 and a basal insulin peptide
Pharmaceutical composition for parenteral administration comprising a basal insulin peptide and an insulinotropic GLP-1 peptide comprising at least 6 zinc atoms per 6 insulin molecules. 用于胃肠外给药的药物组合物,其包括基础胰岛素肽和促胰岛素GLP-1肽,并且包含至少6个锌原子/6个胰岛素分子。...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
01.12.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Pharmaceutical composition for parenteral administration comprising a basal insulin peptide and an insulinotropic GLP-1 peptide comprising at least 6 zinc atoms per 6 insulin molecules.
用于胃肠外给药的药物组合物,其包括基础胰岛素肽和促胰岛素GLP-1肽,并且包含至少6个锌原子/6个胰岛素分子。 |
---|---|
Bibliography: | Application Number: CN201710279962 |